Average Co-Inventor Count = 4.16
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Actym Therapeutics, Inc. (8 from 8 patents)
2. Aduro Biotech Inc. (5 from 29 patents)
3. University of California (2 from 15,458 patents)
4. Chinook Therapeutics, Inc. (2 from 8 patents)
5. Novartis Ag (1 from 3,923 patents)
15 patents:
1. 12357661 - Engineered immunostimulatory bacterial strains and uses thereof
2. 12226439 - Engineered immunostimulatory bacterial strains and uses thereof
3. 12201653 - Engineered immunostimulatory bacterial strains and uses thereof
4. 12024709 - Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
5. 12012600 - Engineered immunostimulatory bacterial strains and uses thereof
6. 11779612 - Engineered immunostimulatory bacterial strains and uses thereof
7. 11242528 - Engineered immunostimulatory bacterial strains and uses thereof
8. 11168326 - Engineered immunostimulatory bacterial strains and uses thereof
9. 11040053 - Compositions and methods for activating 'stimulator of interferon gene'13 dependent signalling
10. 10906930 - Compositions and methods for activating 'stimulator of interferon gene'-dependent signalling
11. 10653774 - Compositions and methods for activating 'stimulator of interferon gene'-dependent signalling
12. 10449211 - Compositions and methods for activating 'stimulator of interferon gene'—dependent signalling
13. 10414789 - Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
14. 9724408 - Compositions and methods for activating stimulator of interferon gene-dependent signalling
15. 9695212 - Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use